Royal Bank of Canada’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-217,500
Closed -$21.6M 7434
2019
Q3
$21.6M Hold
217,500
0.01% 1037
2019
Q2
$20.1M Sell
217,500
-444,700
-67% -$42.2M 0.01% 1091
2019
Q1
$62.5M Buy
662,200
+405,600
+158% +$35.5M 0.03% 485
2018
Q4
$16.4M Buy
256,600
+89,300
+53% +$6.59M 0.01% 1122
2018
Q3
$15M Sell
167,300
-18,400
-10% -$1.63M 0.01% 1324
2018
Q2
$14.7M Sell
185,700
-41,200
-18% -$3.42M 0.01% 1272
2018
Q1
$20.2M Buy
226,900
+220,400
+3,391% +$21.2M 0.01% 1083
2017
Q4
$678K Hold
6,500
﹤0.01% 3556
2017
Q3
$948K Buy
6,500
+1,000
+18% +$136K ﹤0.01% 3259
2017
Q2
$715K Buy
5,500
+3,200
+139% +$392K ﹤0.01% 3373
2017
Q1
$286K Sell
2,300
-45,800
-95% -$5.48M ﹤0.01% 4105
2016
Q4
$5.57M Sell
48,100
-6,800
-12% -$757K ﹤0.01% 1881
2016
Q3
$5.74M Sell
54,900
-26,200
-32% -$2.84M ﹤0.01% 1819
2016
Q2
$8M Sell
81,100
-27,900
-26% -$2.89M ﹤0.01% 1601
2016
Q1
$10.9M Buy
109,000
+29,600
+37% +$3.05M 0.01% 1327
2015
Q4
$9.51M Buy
79,400
+43,400
+121% +$5.02M 0.01% 1463
2015
Q3
$3.89M Sell
36,000
-2,000
-5% -$248K ﹤0.01% 1737
2015
Q2
$4.4M Buy
38,000
+26,000
+217% +$2.97M ﹤0.01% 1705
2015
Q1
$1.38M Sell
12,000
-24,500
-67% -$2.93M ﹤0.01% 2596
2014
Q4
$4.08M Buy
36,500
+13,500
+59% +$1.42M ﹤0.01% 1804
2014
Q3
$2.18M Buy
23,000
+22,000
+2,200% +$1.99M ﹤0.01% 2238
2014
Q2
$86K Sell
1,000
-35,000
-97% -$2.66M ﹤0.01% 4623
2014
Q1
$2.51M Buy
36,000
+20,000
+125% +$1.58M ﹤0.01% 2087
2013
Q4
$1.35M Sell
16,000
-129,000
-89% -$10.2M ﹤0.01% 2593
2013
Q3
$11.2M Buy
+145,000
New +$10.2M 0.01% 1081

Other funds holding CELG

Royal Bank of Canada's CELG Position: Q4 2019 in Review

Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.

Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
  • Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.